News

When it comes to behavioural safety, What you see depends on when you look. That principle sits at the heart of a new multi-company study — just published in Frontiers in Toxicology  — led by Actual Analytics in collaboration with the NC3Rs , AstraZeneca , GSK , Janssen, ICON , Charles River Laboratories , and the University of Edinburgh. The findings matter not only for behavioural science, but for the economics of drug development —Because in drug development, missed CNS s

A new era in safety pharmacology: continuous, automated home-cage monitoring delivers earlier warning of CNS effects and better animal welfare.

We are delighted to welcome Douglas Hutchinson  to Actual Analytics as our new Non-Executive Director . Douglas brings a wealth of...